BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21976935)

  • 21. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema.
    ; Scott IU; Edwards AR; Beck RW; Bressler NM; Chan CK; Elman MJ; Friedman SM; Greven CM; Maturi RK; Pieramici DJ; Shami M; Singerman LJ; Stockdale CR
    Ophthalmology; 2007 Oct; 114(10):1860-7. PubMed ID: 17698196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up.
    Arevalo JF; Fromow-Guerra J; Quiroz-Mercado H; Sanchez JG; Wu L; Maia M; Berrocal MH; Solis-Vivanco A; Farah ME;
    Ophthalmology; 2007 Apr; 114(4):743-50. PubMed ID: 17398322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PERIPHERAL ISCHEMIC RETINAL PHOTOCOAGULATION IN ADDITION TO INTRAVITREAL BEVACIZUMAB VERSUS INTRAVITREAL BEVACIZUMAB ALONE FOR THE TREATMENT OF MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION: A Randomized Double-Masked Controlled Clinical Trial.
    Nourinia R; Emamverdi M; Ramezani A; Amizadeh Y; Khorshidifar M; Behnaz N; Safi S
    Retina; 2020 Jun; 40(6):1110-1117. PubMed ID: 31157710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of diabetic macular edema on peripapillary retinal nerve fiber layer thickness profiles.
    Hwang DJ; Lee EJ; Lee SY; Park KH; Woo SJ
    Invest Ophthalmol Vis Sci; 2014 May; 55(7):4213-9. PubMed ID: 24833740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation.
    Hirano T; Toriyama Y; Iesato Y; Imai A; Hirabayashi K; Nagaoka T; Takamura Y; Sugimoto M; Murata T
    Jpn J Ophthalmol; 2017 Jan; 61(1):51-60. PubMed ID: 27730425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema.
    Soheilian M; Garfami KH; Ramezani A; Yaseri M; Peyman GA
    Retina; 2012 Feb; 32(2):314-21. PubMed ID: 22234244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive factors of outcome of selective retina therapy for diabetic macular edema.
    Yamamoto M; Miura Y; Hirayama K; Kohno T; Kabata D; Theisen-Kunde D; Brinkmann R; Honda S
    Int Ophthalmol; 2020 May; 40(5):1221-1232. PubMed ID: 31950333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 12-month results of the standardised combination therapy for diabetic macular oedema: intravitreal bevacizumab and navigated retinal photocoagulation.
    Barteselli G; Kozak I; El-Emam S; Chhablani J; Cortes MA; Freeman WR
    Br J Ophthalmol; 2014 Aug; 98(8):1036-41. PubMed ID: 24723616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AFLIBERCEPT FOR PERSISTENT DIABETIC MACULAR EDEMA: Forty-Eight-Week Outcomes.
    Bahrami B; Hong T; Schlub TE; Chang AA
    Retina; 2019 Jan; 39(1):61-68. PubMed ID: 30015767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
    Wells JA; Glassman AR; Ayala AR; Jampol LM; Bressler NM; Bressler SB; Brucker AJ; Ferris FL; Hampton GR; Jhaveri C; Melia M; Beck RW;
    Ophthalmology; 2016 Jun; 123(6):1351-9. PubMed ID: 26935357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal injection of methotrexate in persistent diabetic macular edema: a 6-month follow-up study.
    Falavarjani KG; Golabi S; Modarres M
    Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2159-2164. PubMed ID: 27145784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial.
    Mehta H; Fraser-Bell S; Yeung A; Campain A; Lim LL; Quin GJ; McAllister IL; Keane PA; Gillies MC
    Br J Ophthalmol; 2016 Jul; 100(7):1000-1004. PubMed ID: 26537156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in retinal arteriolar microvascular structure associate with higher treatment burden in patients with diabetic macular oedema: results from a 12-month prospective clinical trial.
    Blindbaek SL; Peto T; Grauslund J
    Acta Ophthalmol; 2020 Jun; 98(4):353-359. PubMed ID: 31654501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema.
    Forte R; Cennamo GL; Finelli M; Farese E; D'Amico G; Nicoletti G; de Crecchio G; Cennamo G
    Eye (Lond); 2010 Aug; 24(8):1325-30. PubMed ID: 20300127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema.
    Kim M; Lee P; Kim Y; Yu SY; Kwak HW
    Ophthalmologica; 2011; 226(3):138-44. PubMed ID: 21822008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population.
    Kumar A; Sinha S
    Indian J Ophthalmol; 2007; 55(6):451-5. PubMed ID: 17951903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion.
    Salinas-Alamán A; Zarranz-Ventura J; Caire González-Jauregui JM; Sádaba-Echarri LM; Barrio-Barrio J; García-Layana A
    Eur J Ophthalmol; 2011; 21(4):434-9. PubMed ID: 21140369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of fundus autofluorescence with spectral-domain optical coherence tomography and vision in diabetic macular edema.
    Chung H; Park B; Shin HJ; Kim HC
    Ophthalmology; 2012 May; 119(5):1056-65. PubMed ID: 22342014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical Lessons from Protocol I for the Management of Diabetic Macular Edema.
    Mukkamala L; Bhagat N; Zarbin MA
    Dev Ophthalmol; 2017; 60():91-108. PubMed ID: 28427069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.